Study Subject Participation Status Clinical Trial Specified | FdCyd | THU | Target Lesion Size Spiral CT
Item
enrolled in the nih phase ii clinical protocol evaluating fdcyd with thu (09-c-0214) with target lesion measured as greater than or equal to 10mm with spiral ct scan.
boolean
C2348568 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
C0049174 (UMLS CUI [2])
C0039677 (UMLS CUI [3])
C2986546 (UMLS CUI [4,1])
C0456389 (UMLS CUI [4,2])
C0860888 (UMLS CUI [4,3])
Informed Consent
Item
written, voluntary, informed consent of the patient must be obtained in compliance with institutional, state and federal guidelines
boolean
C0021430 (UMLS CUI [1])
Gender Serum pregnancy test negative | Postmenopausal state | Hysterectomy
Item
for females: negative serum pregnancy test or post-menopausal for at least 2 years or patient has had a hysterectomy
boolean
C0079399 (UMLS CUI [1,1])
C0430061 (UMLS CUI [1,2])
C0232970 (UMLS CUI [2])
C0020699 (UMLS CUI [3])
Claustrophobia Severe | Unresponsive to Anti-Anxiety Agents Oral
Item
participants with severe claustrophobia unresponsive to oral anxiolytics
boolean
C0008909 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205269 (UMLS CUI [2,1])
C0040616 (UMLS CUI [2,2])
C1527415 (UMLS CUI [2,3])
Body Weight | Body Weight Inappropriate Scanner | Study Subject Inappropriate Imaging Technique
Item
subjects weighing > 400 lbs (weight limit for scanner table), or unable to fit within the imaging gantry
boolean
C0005910 (UMLS CUI [1])
C0005910 (UMLS CUI [2,1])
C1548788 (UMLS CUI [2,2])
C1710020 (UMLS CUI [2,3])
C0681850 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C0079595 (UMLS CUI [3,3])
Hypersensitivity FdCyd
Item
known allergy to fdcyd
boolean
C0020517 (UMLS CUI [1,1])
C0049174 (UMLS CUI [1,2])
Lacking Able to lie down Quiet Duration
Item
the subject is unable to lie still for 75 minutes
boolean
C0332268 (UMLS CUI [1,1])
C0560841 (UMLS CUI [1,2])
C0439654 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
Pregnancy | Breast Feeding
Item
5 pregnant or lactating women. pregnant women are excluded from this study because the effects of 18f-fdcyd in pregnancy are not known. because there is an unknown but potential risk for adverse events in nursing infants secondary to administration of 18ffdcyd in the mother, breastfeeding should be discontinued if the mother receives 18ffdcyd
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Medical condition Interferes with Interventional procedure | Mental condition Interferes with Interventional procedure | Medical condition Interferes with Research results | Mental condition Interferes with Research results
Item
participants with any co-existing medical or psychiatric condition that is likely to interfere with study procedures and/or results
boolean
C3843040 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0184661 (UMLS CUI [1,3])
C3840291 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0184661 (UMLS CUI [2,3])
C3843040 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0683954 (UMLS CUI [3,3])
C3840291 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0683954 (UMLS CUI [4,3])